Atlanta Institute-Medicine is categorized under in Atlanta, GA and active since 1996.
Atlanta Institute-Medicine was established in 1996, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a business, which does work in the B2B market, and is classified as a , under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Chris Chin, Office Manager at the company’s single location by writing to 5901 Peachtree Dunwoody Road # A200, Atlanta, Georgia GA 30328 or by phoning (770) 817-9200. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Atlanta Institute-Medicine |
| Contact Person: | Chris Chin, Office Manager |
| Address: | 5901 Peachtree Dunwoody Road # A200, Atlanta, Georgia 30328 |
| Phone Number: | (770) 817-9200 |
| Website Address: | researchmed.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1996 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | |
| SIC Code: | 6153 |
| NAICS Code: | 6211110 |
| Share This Business: |
Atlanta Institute-Medicine was started in 1996 to provide professional under the SIC code 6153 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Chris Chin, Office Manager for inquiries that concern Atlanta Institute-Medicine by calling the company number (770) 817-9200, as your correspondence is most welcome. Additionally, the physical location of the single location of Atlanta Institute-Medicine can be found at the coordinates 33.913875,-84.351899 as well as the street address 5901 Peachtree Dunwoody Road # A200 in Atlanta, Georgia 30328.
For its online presence, you may visit Atlanta Institute-Medicine’s website at researchmed.com and engage with its social media outlets through on Twitter and on Facebook.